#HepatitisB
Can #HepatitisB treatment improve viral control while remaining safe?

Tenofovir amibufenamide showed stronger #antiviral efficacy than #TenofovirAlafenamide formulations, while centralized procurement offered cost advantages. #medsky

#currentmedicalscience: doi.org/10.1007/s115...
November 3, 2026 at 1:45 PM
📢 Open Access!
"Long-term patient and graft survival for children and young adults after kidney transplantation and re-transplantation – results from the ERA Registry," by Preka et al
buff.ly/OuUVFsu
#LiverTransplantation #Transplantation #HepatitisB #OrganDonation
November 2, 2026 at 1:03 PM
La FDA aprueba bepirovirsen: terapia para hepatitis B con curación funcional en 19% (26% con HBsAg bajo), vs 0% en control y <1% con antivirales. #HepatitisB #Salud
Una nueva terapia abre la puerta a la curación de la hepatitis B: "Estamos ante una noticia muy esperanzadora"
aidoo.news
October 27, 2026 at 1:07 PM
New hope in #hepatitisB: the US FDA approved #Hibsago #bepirovirsen, an RNA-targeting injection. In Phase III trials, 19% achieved functional cure vs 0% on placebo. Sustained viral control without treatment, not eradication. Only selected #HepB patients qualify. lnkd.in/p/ehzZ6eun
October 26, 2026 at 4:02 PM
🧪 #HepatitisB 💉
#mustread 🧵 outstanding reporting by @melodyschreiber.com
BREAKING: The hepatitis B vaccine trial in Guinea-Bissau "will not move forward," the lead researcher says.

“The solution is clear here: Take the money and vaccinate as many kids as you can,” @pauloffit.bsky.social told me:
www.theguardian.com/world/2026/o...
Controversial US-backed vaccine trial in African newborns halted
Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’
www.theguardian.com
October 22, 2026 at 5:02 AM
I’m still thinking of this unethical trial and I’m trying to understand what they even thought they wanted to achieve. If the non specific effects would cause more death and morbidity than hepatitisB, then it would have been obvious in the vaccine trials.

www.linkedin.com/pulse/missed...
A missed opportunity for Guinea-Bissau’s children: Why the HBV-NSE trial will not proceed
It is now clear that the HBV-NSE trial will not move forward in Guinea-Bissau – we were not given the necessary governmental approval. During the conduct of the trial, our teams would have tested 17,0...
www.linkedin.com
October 25, 2026 at 11:01 PM
Email your Members of Congress and demand RFK Jr stops experimenting on babies in Guinea-Bissau

#HepatitisB #Vaccines
https://fight2win.standupforscience.net/campaign/GB_study_write
Stand up for Science
Stand up for Science
fight2win.standupforscience.net
October 21, 2026 at 1:41 PM
Die FDA hat das #HepatitisB- Medikament Hibsago (Wirkstoff: Bepirovirsen) in Kombination mit anderen antiviralen Medikamenten zugelassen. Hibsago ermöglicht erstmals in relevantem Umfang (bei rund einem Fünftel der Patient*innen) eine funktionelle Heilung einer chronischen Hepatitis B.
FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment
FDA today approved Hibsago (bepirovirsen) injection, in combination with existing antiviral therapy, to treat chronic hepatitis B virus (HBV) infection in certain adults without cirrhosis.
www.fda.gov
October 22, 2026 at 6:26 AM
#NytOmTrump
Danskere (bla. #FrederikSchaltz-Buchholzer) involveret i klinisk forsøg, der nægter #hepatitisB #vaccine til 7.000 ikke-hvide børn i #Guinea-Bissau,hvor den er udbredt.

Det skulle være godkendt af #sdu etisk råd... 😳
#dkpol #dkmedier

Deres kontorer blev ransaget af lokal politi.
#USA
That feeling when you (RFK Jr) give 1.6M to fund a widely protested, unnecessary unethical clinical trial on vulnerable new borns, only to find out that those Danish scientists GOT RAIDED by the local police…

That’s how bad this is.
Wow.

🧪 www.theguardian.com/world/2026/o...
RFK Jr’s ‘deities of vaccine research’ raided by police in Guinea-Bissau
Police seize doses of hepatitis B vaccine from people at center of dispute over research on African newborns
www.theguardian.com
October 21, 2026 at 6:15 AM
Email your Members of Congress and demand RFK Jr stops experimenting on babies in Guinea-Bissau

#hepatitisb #vaccines
https://fight2win.standupforscience.net/campaign/GB_study_write
Stand up for Science
Stand up for Science
fight2win.standupforscience.net
October 21, 2026 at 1:41 PM
Exciting new era in our ability to cure #hepatitisB let’s go—we need a global strategy to bring this to everyone @aasldnews.bsky.social @idsainfo.bsky.social www.medpagetoday.com/infectiousdi...
FDA Green Lights Potential Functional Cure for Chronic Hep B
'Start of a new era,' says trial investigator
www.medpagetoday.com
October 21, 2026 at 2:29 PM
In the news:
RFK Jr’s eugenic friends wanted to run unethical HepatitisB vaccines trails on newborns in Guinea Bissau.

In other news:
Yep, you guessed it, approximately 99% of the population of Guinea-Bissau is Black (African).

arstechnica.com/health/2026/...
Cops raid office of RFK Jr. allies planning “unethical” vaccine trial on babies
Guinea-Bissau police said hepatitis B vaccine doses were taken as part of an investigation.
arstechnica.com
October 21, 2026 at 12:35 AM
#GSK 's antisense-based drug for chronic #hepatitisB virus (HBV) infection, Hibsago, has been approved in the US, its second major market after Japan.
GSK wins FDA green light for chronic hep B treatment Hibsago
GSK's antisense-based drug for chronic hepatitis B virus (HBV) infection, Hibsago, has been approved in the US, its second major market after Japan.
pharmaphorum.com
October 21, 2026 at 1:50 PM
Ending routine #vaccination for #hepatitisB at birth, as #RFK has recommended, would increase the number of chronic infections by as much as 83 percent, a team of researchers reported. #publichealth
Kennedy’s Vaccine Plan Could Cause Surge in Hepatitis B, Study Finds
Ending routine vaccination for hepatitis B at birth, as the health secretary has recommended, would increase the number of chronic infections by as much as 83 percent, a team of researchers reported.
www.nytimes.com
October 20, 2026 at 1:16 PM
💉🦠 A modeling study projects that delaying the newborn #HepatitisB #vaccine to 2 months could increase chronic childhood #infections by 19%, while a shared decision-making approach could raise them by 83%.

#PublicHealth #Microsky via @sciencex.bsky.social

medicalxpress.com/news/2026-10...
Proposed changes to hepatitis B vaccination schedule could significantly increase infections, model suggests
A modeling study suggests that replacing universal hepatitis B vaccination at birth with delayed vaccination or a shared decision-making approach, as recommended by the U.S. federal government this…
medicalxpress.com
October 21, 2026 at 4:31 PM
6-month regimen of experimental drug for #HepatitisB virus (HBV) + standard antivirals has “functionally cured” 19% of people in 2 efficacy trials, naturally control the virus without any further treatments, MAYBE. Results from chronic #HBV infections. scim.ag/4v8vjdU
New drug ‘functionally cures’ many hepatitis B virus infections
GSK’s “bepi” performs better than expected in efficacy trials, but its global impact is likely limited
scim.ag
October 20, 2026 at 10:50 AM
October is Liver Cancer Awareness Month.

People with Hepatitis B are at increased risk of liver cancer. Early detection can save a life. Get screened today!

Learn more here: www.hepb.org/news-and-eve...

#LiverCancerAwarenessMonth #HepatitisB #LiverCancer
October 19, 2026 at 4:03 PM
A U.S. model published Oct. 20 projects that delaying the hepatitis B vaccine birth dose or making it a shared decision could increase chronic infections among children by 19% to 83% compared with vaccinating all infants at birth.

#HepatitisB #BirthDoseVaccination #VaccinePolicy
[AI]
U.S. Model Projects Hepatitis B Birth-Dose Policy Changes Could Increase Infections
A U.S. model projects delaying the hepatitis B birth dose or using shared decision-making could raise chronic infections among children by 19% to 83%.
harava.news
October 20, 2026 at 6:49 AM
October 16, 2026 at 3:21 PM